reMYND | Driving the development of disease-modifying treatments
We drive the development of disease-modifying treatments against Alzheimer’s, Parkinson’s, Diabetes and other protein misfolding disorders.
reMynd, Contract Research Organization, Drug Discovery and Development, Alzheimer’s, Parkinson’s, Diabetes, TAU model, APP model
Is this your site? Certify your site and update informations
